TargetMol

VL-0395

Product Code:
 
TAR-T29108
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T29108-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T29108-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T29108-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
VL-0395 is an antagonist of CCK1 receptor.
CAS:
620167-11-5
Formula:
C26H23N5O4
Molecular Weight:
469.501
Purity:
0.98
SMILES:
NC(=N)c1ccc2[nH]c(cc2c1)C(=O)Nc1cccc(c1)C(=O)NC(CC(O)=O)c1ccccc1

References

1. Pavan MV, Lassiani L, Berti F, Stefancich G, Ciogli A, Gasparrini F, Mennuni L, Ferrari F, Escrieut C, Marco E, Makovec F, Fourmy D, Varnavas A. New anthranilic acid based antagonists with high affinity and selectivity for the human cholecystokinin receptor 1 (hCCK1-R). J Med Chem. 2011 Aug 25;54(16):5769-85. doi: 10.1021/jm200438b. Epub 2011 Jul 20. PubMed PMID: 21728335. 2. Lassiani L, Pavan MV, Berti F, Kokotos G, Markidis T, Mennuni L, Makovec F, Varnavas A. Anthranilic acid based CCK1 receptor antagonists: blocking the receptor with the same 'words' of the endogenous ligand. Bioorg Med Chem. 2009 Mar 15;17(6):2336-50. doi: 10.1016/j.bmc.2009.02.012. Epub 2009 Feb 14. PubMed PMID: 19261479. 3. Varnavas A, Lassiani L, Valenta V, Ciogli A, Gasparrini F, Mennuni L, Makovec F. N-terminal anthranoyl-phenylalanine derivatives as CCK1 receptor antagonists: the final approach. Med Chem. 2005 Sep;1(5):501-17. PubMed PMID: 16787335. 4. De Luca S, Saviano M, Lassiani L, Yannakopoulou K, Stefanidou P, Aloj L, Morelli G, Varnavas A. Anthranilic acid based CCK1 receptor antagonists and CCK-8 have a common step in their "receptor desmodynamic processes". J Med Chem. 2006 Apr 20;49(8):2456-62. PubMed PMID: 16610788.